Skip to main content

Table 1 Clinical data of the ESFT patients included in array CGH and/or data integration analysis.

From: Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors

Code Included in data integration analysis Diagnosis Origin
of sample 		Chemotherapy or radiation before sample collection Material from Necrosis Patient Status at Diagnosis Age Sex Location Outcome
EFS 		EFS months Outcome
OVS 		OVS months Type of Translocation
D150 X Ewing PRI no Biopsy   Localized 23 M Femur REL 6 DEAD 12 EWS/FLI-1
type 2
D152 X Ewing PRI no Biopsy   Pri Met Lung 15 M Pelvis REL 8 DEAD 17 EWS/FLI-1
type 2
D153 X Ewing PRI no Biopsy   Pri Met Bone 22 M Pelvis REL 0 DEAD 5 EWS/FLI-1
type 3
D154 X Ewing PRI yes Resection 50% Localized 19 M Humerus REL 19 AWD 57 Neg/Neg
D155   Ewing PRI no Biopsy   Localized 15 F Pelvis NED 69 NED 69 EWS/FLI-1
type 1
D162   Ewing PRI yes Resection 90% Localized 20 M Tibia NED 61 NED 61 Neg/Neg
D239   Ewing PRI yes Resection 95% Localized 21 F Scapula REL 34 NED 41 EWS/FLI-1
type 2
D240   Ewing PRI yes Resection 30% Pri Met Lung 10 F Humerus REL 13 DEAD 15 EWS/FLI-1
type 1
D241   Ewing PRI yes Resection > 95% Localized 28 M Femur NED 47 NED 47 EWS/FLI-1
type 2
D245   Ewing PRI yes Resection 70% Localized 22 M Radius REL 4 DEAD 8 NA
D248   Ewing PRI yes Resection 95% Localized 11 M Scapula NED 76 NED 76 EWS/FLI-1
type 1
D250   Ewing PRI yes Resection 75% Pri Met Lung 32 F Clavicula REL 20 DEAD 31 Neg/Neg
D311 X Ewing PRI no Biopsy   Localized 13 M Pelvis NED 43 NED 43 EWS/FLI-1
type 1
D313 X Ewing PRI no Biopsy   Localized 24 M Femur REL 18 NED 117 EWS/FLI-1
type 1
D316 X Ewing PRI yes Resection 60% Pri Met Lung 11 M Femur REL 10 DEAD 10 EWS/FLI-1
type 1
D320 X Ewing PRI no Biopsy   Localized 5 M Humerus REL 14 DEAD 21 EWS/FLI-1
type 2
D322 X Ewing PRI yes Resection 25% Localized 27 F Femur REL 29 NED 67 EWS/FLI-1
type 1
D242   Ewing Extr PRI no Biopsy   Localized 41 F Thorax NED 56 NED 56 NA
D246   Ewing Extr PRI no Biopsy   Localized 26 F Thigh NED 49 NED 49 EWS/FLI-1
type 1
D249   Ewing Extr PRI no Biopsy   Localized 35 M Thigh REL 7 AWD 13 NA
D252   Ewing Extr PRI no Biopsy   Pri Met Lung 18 M Thigh REL 0 DEAD 13 EWS/FLI-1
type 1
D253   Askin's PRI yes Resection 10% Localized 24 M Rib REL 5 DEAD 12 EWS/FLI-1
type 2
D254   Askin's PRI yes Resection 15% Pri Met Lung 21 M Rib NA NA NA NA NA
D156   Askin's REC no Resection   Localized 15 M Rib REL 17 DEAD 21 EWS/FLI-1
type 1
D157 X Ewing REC no Amputation   Pri Met Lung 30 F Femur REL 3 DEAD 25 EWS/FLI-1
type 1
D255 X Ewing LUNG MET no Resection   Pri Met Lung 17 M Scapula REL 31 DEAD 43 EWS/FLI-1
type 1
D256 X Ewing LUNG MET no Resection   Localized 34 M Humerus REL 17 NED 136 EWS/FLI-1
type 1
D312 X Ewing LUNG MET no Resection   Localized 9 M Fibula REL 28 DEAD 42 EWS/FLI-1
type 1
D321 X Ewing LUNG MET no Lobectomy   Localized 24 M Pelvis REL 34 DEAD 80 EWS/FLI-1
type 1
D315 X PNET BONE MET no Biopsy   Localized 16 M Tibia REL 58 DEAD 99 EWS/FLI-1
type 1
D257 X PNET BONE MET no Biopsy   Localized 16 F Femur REL 6 DEAD 8 EWS/FLI-1
type 2
  1. Extr = extraskeletal; PRI = primary tumor; REC = local recurrence; MET L = metastasis in lung; MET B = metastasis in bone; EFS = event-free survival; REL = relapsed; NED = no evidence of disease; NA = not available; OVS = overall survival; AWD = alive with disease.
Back to article page